SAT0396 Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 737.2-738
◽
Keyword(s):
Phase 3
◽
Keyword(s):